From Medscape Oncology

Coverage from the

World Congress on Gastrointestinal Cancer 2018

June 20 - 23, 2018; Barcelona, Spain

June 20 - 23, 2018 Barcelona, Spain
  • WCGC 2018 Explosion in GI Cancer Drugs 'Confusing for Clinicians' Clinicians have a confusing picture of which drugs to choose for gastrointestinal cancers, owing to the way trials are designed, although help is at hand from clinical assessment tools, argue experts.
  • WCGC 2018 Gut Microbiome 'May Hold Key to Immunotherapy Outcomes' The microbial make-up of the gut, or microbiome, appears to play a key role in the risk for colorectal cancer, as well as whether immunotherapies will be successful.

Conference News

Popular News from WCGC 2017

  • Liver SIRT Benefit in Advanced Right-Sided CRC Liver SIRT Benefit in Advanced Right-Sided CRC Patients with metastatic colorectal cancer originating on the right colon experience a significant survival benefit by adding selective internal radiotherapy to chemotherapy, say researchers.
  • Gastric Cancer Treatment Choice: Look at Tumor Profile Gastric Cancer Treatment Choice: Look at Tumor Profile In the management of gastric cancer, the choice of second-line therapy with angiogenesis inhibitors or checkpoint inhibitors should be based on individual tumor characteristics, say experts.
  • Patient Selection Key in Managing Gastrointestinal Tumors Patient Selection Key in Managing Gastrointestinal Tumors Protein biomarkers and clinical factors can have a marked effect on clinical outcomes in gastrointestinal tumors and should be taken into account during patient selection, argue leading experts.

Medscape Oncology© 

Previous Coverage